Division of Drug Discovery and Safety (DDS), Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, The Netherlands.
Institute of Physics, University of Freiburg, 79104, Freiburg, Germany.
Sci Rep. 2022 May 5;12(1):7336. doi: 10.1038/s41598-022-10857-x.
Cells are exposed to oxidative stress and reactive metabolites every day. The Nrf2 signaling pathway responds to oxidative stress by upregulation of antioxidants like glutathione (GSH) to compensate the stress insult and re-establish homeostasis. Although mechanisms describing the interaction between the key pathway constituents Nrf2, Keap1 and p62 are widely reviewed and discussed in literature, quantitative dynamic models bringing together these mechanisms with time-resolved data are limited. Here, we present an ordinary differential equation (ODE) based dynamic model to describe the dynamic response of Nrf2, Keap1, Srxn1 and GSH to oxidative stress caused by the soft-electrophile diethyl maleate (DEM). The time-resolved data obtained by single-cell confocal microscopy of green fluorescent protein (GFP) reporters and qPCR of the Nrf2 pathway components complemented with siRNA knock down experiments, is accurately described by the calibrated mathematical model. We show that the quantitative model can describe the activation of the Nrf2 pathway by compounds with a different mechanism of activation, including drugs which are known for their ability to cause drug induced liver-injury (DILI) i.e., diclofenac (DCF) and omeprazole (OMZ). Finally, we show that our model can reveal differences in the processes leading to altered activation dynamics amongst DILI inducing drugs.
细胞每天都会受到氧化应激和反应性代谢物的影响。Nrf2 信号通路通过上调抗氧化剂如谷胱甘肽 (GSH) 来应对氧化应激,以补偿应激损伤并重新建立体内平衡。尽管描述 Nrf2、Keap1 和 p62 等关键通路成分之间相互作用的机制在文献中得到了广泛的综述和讨论,但将这些机制与时间分辨数据结合起来的定量动态模型仍然有限。在这里,我们提出了一个基于常微分方程 (ODE) 的动态模型,用于描述 Nrf2、Keap1、Srxn1 和 GSH 对软亲电试剂二乙基马来酸酯 (DEM) 引起的氧化应激的动态响应。通过对绿色荧光蛋白 (GFP) 报告基因的单细胞共聚焦显微镜和 Nrf2 通路成分的 qPCR 获得的时间分辨数据,通过校准的数学模型进行了准确描述。我们表明,定量模型可以描述具有不同激活机制的化合物对 Nrf2 通路的激活,包括已知具有引起药物性肝损伤 (DILI) 能力的药物,即双氯芬酸 (DCF) 和奥美拉唑 (OMZ)。最后,我们表明,我们的模型可以揭示导致 DILI 诱导药物激活动力学改变的过程之间的差异。